UC Berkeley institute to end COVID-19 saliva test trial
Irene Yi/Courtesy
The Innovative Genomics Institute will conclude its study on saliva-based testing for COVID-19 on Oct. 29. As of Oct. 7, all students at UC Berkeley have been able to receive free asymptomatic COVID-19 testing at the Recreational Sports Facility and Memorial Stadium.
UC Berkeley’s Innovative Genomics Institute, or IGI’s, Free Asymptomatic Saliva Test, or FAST, study for COVID-19 will end Thursday after having tested more than 4,800 people, according Jennifer Doudna, president and chair of the IGI governance board
Read More…
